TCL Archive Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO May 25, 2007
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014